IL21 and permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome: Here, we demonstrate that IL-21 significantly improves the therapeutic efficacy associated with VV CTRL treatment in PaCa models via beneficial remodeling of immune elements of the TME, importantly macrophages, and engagement of adaptive immune responses.